Results from London Regional Clinical Genetics services over a 5-year period on germline TP53 testing in women diagnosed with breast cancer at< 30 years
A Garrett, S Talukdar, L Izatt, AF Brady… - Journal of Medical …, 2022 - jmg.bmj.com
Background The most common cancer diagnosed in germline TP53 pathogenic variant (PV)
carriers is premenopausal breast cancer. An increased rate of breast tumour HER2 positivity …
carriers is premenopausal breast cancer. An increased rate of breast tumour HER2 positivity …